These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36717607)

  • 21. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero.
    Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376
    [No Abstract]   [Full Text] [Related]  

  • 22. Racial differences in opioid withdrawal syndrome among neonates with intrauterine opioid exposure.
    Pourcyrous M; Elabiad MT; Rana D; Gaston KP; DeBaer L; Dhanireddy R
    Pediatr Res; 2021 Aug; 90(2):459-463. PubMed ID: 33214673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examination of Hospital, Maternal, and Infant Characteristics Associated with Breastfeeding Initiation and Continuation Among Opioid-Exposed Mother-Infant Dyads.
    Schiff DM; Wachman EM; Philipp B; Joseph K; Shrestha H; Taveras EM; Parker MGK
    Breastfeed Med; 2018 May; 13(4):266-274. PubMed ID: 29630387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors.
    Bakhireva LN; Sparks A; Herman M; Hund L; Ashley M; Salisbury A
    Pediatr Res; 2022 Mar; 91(4):867-873. PubMed ID: 34588611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
    Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
    JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How Might Maternal Poverty Impact the Course of Neonatal Opioid Withdrawal Syndrome?
    Wachman EM
    J Addict Med; 2020; 14(2):93-94. PubMed ID: 31149916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Coronavirus Disease-2019 on Hospital Care for Neonatal Opioid Withdrawal Syndrome.
    MacMillan KDL; Morrison TM; Melvin P; Diop H; Gupta M; Wachman EM
    J Pediatr; 2022 Jun; 245():47-55. PubMed ID: 35131283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric Hospital Readmissions for Infants With Neonatal Opioid Withdrawal Syndrome, 2016-2019.
    Milliren CE; Melvin P; Ozonoff A
    Hosp Pediatr; 2021 Sep; 11(9):979-988. PubMed ID: 34417200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS).
    Czynski A; Laptook A; Das A; Smith B; Simon A; Greenberg R; Annett R; Lee J; Snowden J; Pedroza C; Lester B; Eggleston B; Bremer D; McGowan E
    Trials; 2023 Jul; 24(1):466. PubMed ID: 37480087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospital Readmissions Among Infants With Neonatal Opioid Withdrawal Syndrome.
    Gaither JR; Drago MJ; Grossman MR; Li Y; Shabanova V; Xu X; Leventhal JM
    JAMA Netw Open; 2024 Sep; 7(9):e2435074. PubMed ID: 39316398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of In-utero Exposure to Selective Serotonin Reuptake Inhibitors and Opioids on Neonatal Opioid Withdrawal Syndrome.
    Bhatt-Mehta V; Richards J; Sturza J; Schumacher RE
    J Addict Med; 2019; 13(3):227-234. PubMed ID: 30489344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal Opioid Withdrawal Syndrome: A Comparison of As-Needed Pharmacotherapy.
    Morrison TM; MacMillan KDL; Melvin P; Singh R; Murzycki J; Van Vleet MW; Rothstein R; O'Shea TF; Gupta M; Schiff DM; Wachman EM
    Hosp Pediatr; 2022 May; 12(5):530-538. PubMed ID: 35403199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
    Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
    Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
    Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
    Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors Associated With the Need for Pharmacological Management of Neonatal Opioid Withdrawal Syndrome.
    Scott LF; Guilfoy V; Duwve JM; Rawl SM
    Adv Neonatal Care; 2020 Oct; 20(5):364-373. PubMed ID: 32868586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine.
    O'Connor AB; Kelly BK; O'Brien LM
    Drug Alcohol Depend; 2017 Nov; 180():200-203. PubMed ID: 28917206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Avoiding NICU Transfers for Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS): A Quality Improvement Initiative to Manage NOWS on the Mother-baby Unit.
    Spence K; Boedeker R; Harhausen M; Kaushal G; Buchanan P; Josephsen J
    J Addict Med; 2020; 14(5):401-408. PubMed ID: 31972766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and outcomes of neonatal opioid withdrawal syndrome in preterm infants: a retrospective cohort study in the current era.
    Heyward A; Minich N; Hoffman AC; Hibbs AM; Zhao L; Crowley M
    J Perinatol; 2023 Jul; 43(7):909-915. PubMed ID: 37188773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder.
    Kanervo MM; Tupola SJ; Nikkola EM; Rantakari KM; Kahila HK
    Acta Obstet Gynecol Scand; 2023 Mar; 102(3):313-322. PubMed ID: 36562462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.